UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038954
Receipt number R000044423
Scientific Title Study on characteristics and usefulness of breast DWI.
Date of disclosure of the study information 2020/01/01
Last modified on 2019/12/22 22:12:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on characteristics and usefulness of breast DWI.

Acronym

Study on characteristics and usefulness of breast DWI.

Scientific Title

Study on characteristics and usefulness of breast DWI.

Scientific Title:Acronym

Study on characteristics and usefulness of breast DWI.

Region

Japan


Condition

Condition

Breast lesions

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Non-contrast MRI DWI images are expected to be a noninvasive screening test for breast cancer high-risk groups, but are known to have low lesion delineation output.
In this study, we examine the features and usefulness of DWI imaging by examining cases in which histological examination was performed for mammography MRI and breast lesions.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To evaluate the differential diagnostic ability of DWI images for benign or malignant breast lesions.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Cases who have undergone contrast-enhanced MRI and have confirmed histopathological diagnosis.
2. Patients who did not refuse inclusion in this clinical trial.

Key exclusion criteria

1. Patients without contrast-enhanced MRI or clinicopathological diagnosis.
2. Patients who refused to be included in this clinical trial.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Shinsaku
Middle name
Last name KANAZAWA

Organization

SUNKOKAI KOGA Hospital

Division name

Breast Surgery

Zip code

425-0088

Address

2-30-1, Daikakuji, Yaizu-shi, Shizuoka

TEL

0546285500

Email

shikanazawa-gi@umin.net


Public contact

Name of contact person

1st name Shinsaku
Middle name
Last name KANAZAWA

Organization

SUNKOKAI KOGA Hospital

Division name

Breast Surgery

Zip code

425-0088

Address

2-30-1, Daikakuji, Yaizu-shi, Shizuoka

TEL

0546285500

Homepage URL


Email

shikanazawa-gi@umin.net


Sponsor or person

Institute

SUNKOKAI KOGA Hospital

Institute

Department

Personal name



Funding Source

Organization

SUNKOKAI KOGA Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

SUNKOKAI KOGA Hospital

Address

2-30-1, Daikakuji, Yaizu-shi, Shizuoka

Tel

0546285500

Email

shikanazawa-gi@umin.net


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 03 Month 01 Day

Date of IRB

2019 Year 12 Month 20 Day

Anticipated trial start date

2019 Year 03 Month 01 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2019 Year 12 Month 22 Day

Last modified on

2019 Year 12 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044423


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name